Part 7.4: Monitoring and medications

Circulation

Volumn 112, Issue 24 SUPPL., 2005, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMRINONE; BICARBONATE; BUMETANIDE; CALCIUM; CHLOROTHIAZIDE; DIGITALIS; DIGOXIN ANTIBODY F(AB) FRAGMENT; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; METOLAZONE; MILRINONE; NITROPRUSSIDE SODIUM; NORADRENALIN; THIAZIDE DIURETIC AGENT; TORASEMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; VASOPRESSIN;

ARTERIAL GAS; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; END TIDAL CARBON DIOXIDE TENSION; HEART ARREST; HEMODYNAMICS; HUMAN; HYPOTENSION; NAUSEA; PATIENT MONITORING; PRIORITY JOURNAL; PULSE OXIMETRY; TACHYCARDIA; VOMITING;

EID: 33744801434     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.166559     Document Type: Conference Paper

References (73)

1. Levine RL, Wayne MA, Miller CC. End-tidal carbon dioxide and outcome of out-of-hospital cardiac arrest. N Engl J Med. 1997;337: 301-306.
2. Wayne MA, Levine RL, Miller CC. Use of end-tidal carbon dioxide to predict outcome in prehospital cardiac arrest. Ann Emerg Med. 1995;25: 762-767.
3. Paradis NA, Martin GB, Rivers EP, Goetting MG, Appleton TJ, Feingold M, Nowak RM. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA. 1990;263:1106-1113.
4. Halperin HR, Tsitlik JE, Gelfand M, Weisfeldt ML, Gruben KG, Levin HR, Rayburn BK, Chandra NC, Scott CJ, Kreps BJ, et al. A preliminary study of cardiopulmonary resuscitation by circumferential compression of the chest with use of a pneumatic vest. N Engl J Med. 1993;329:762-768.
5. Kern KB, Ewy GA, Voorhees WD, Babbs CF, Tacker WA. Myocardial perfusion pressure: a predictor of 24-hour survival during prolonged cardiac arrest in dogs. Resuscitation. 1988;16:241-250.
6. Lindner KH, Prengel AW, Pfenninger EG, Lindner IM, Strohmenger HU, Georgieff M, Lurie KG. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation. 1995;91:215-221.
7. Little CM, Angelos MG, Paradis NA. Compared to angiotensin II, epinephrine is associated with high myocardial blood flow following return of spontaneous circulation after cardiac arrest. Resuscitation. 2003;59: 353-359.
8. Connick M, Berg RA. Femoral venous pulsations during open-chest cardiac massage. Ann Emerg Med. 1994;24:1176-1179.
9. Weil MH, Rackow EC, Trevino R, Grundler W, Falk JL, Griffel MI. Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med. 1986;315:153-156.
10. Kette F, Weil MH, Gazmuri RJ, Bisera J, Rackow EC. Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med. 1993;21:901-906.
11. Adrogue HJ, Rashad MN, Gorin AB, Yacoub J, Madias NE. Arteriovenous acid-base disparity in circulatory failure: studies on mechanism. Am J Physiol. 1989;257:F1087-F1093.
12. Tucker KJ, Idris AH, Wenzel V, Orban DJ. Changes in arterial and mixed venous blood gases during untreated ventricular fibrillation and cardiopulmonary resuscitation. Resuscitation. 1994;28:137-141.
13. Tang W, Weil MH, Sun S, Kette D, Gazmuri RJ, O'Connell F, Bisera J. Cardiopulmonary resuscitation by precordial compression but without mechanical ventilation. Am J Respir Crit Care Med. 1994;150: 1709-1713.
14. Gudipati CV, Weil MH, Gazmuri RJ, Deshmukh HG, Bisera J, Rackow EC. Increases in coronary vein CO2 during cardiac resuscitation. J Appl Physiol. 1990;68:1405-1408.
15. Capparelli EV, Chow MS, Kluger J, Fieldman A. Differences in systemic and myocardial blood acid-base status during cardiopulmonary resuscitation. Crit Care Med. 1989;17:442-446.
16. von Planta M, Weil MH, Gazmuri RJ, Bisera J, Rackow EC. Myocardial acidosis associated with CO2 production during cardiac arrest and resuscitation. Circulation. 1989;80:684-692.
17. Grundler W, Weil MH, Rackow EC. Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation. 1986;74:1071-1074.
18. Sanders AB, Ewy GA, Taft TV. Resuscitation and arterial blood gas abnormalities during prolonged cardiopulmonary resuscitation. Ann Emerg Med. 1984;13:676-679.
19. Nowak RM, Martin GB, Carden DL, Tomlanovich MC. Selective venous hypercarbia during human CPR: implications regarding blood flow. Ann Emerg Med. 1987;16:527-530.
20. American Heart Association in collaboration with International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science, Part 6: Advanced Cardiovascular Life Support: Section 4: Devices to Assist Circulation. Circulation. 2000;102(suppl I):I105-I111.
21. Abraham E, Fink S. Conjunctival oxygen tension monitoring in emergency department patients. Am J Emerg Med. 1988;6:549-554.
22. Bhende MS, Thompson AE. Evaluation of an end-tidal CO2 detector during pediatric cardiopulmonary resuscitation. Pediatrics. 1995;95: 395-399.
23. Callaham M, Barton C. Prediction of outcome of cardiopulmonary resuscitation from end-tidal carbon dioxide concentration. Crit Care Med. 1990;18:358-362.
24. Grmec S, Klemen P. Does the end-tidal carbon dioxide (EtCO2) concentration have prognostic value during out-of-hospital cardiac arrest? Eur J Emerg Med. 2001;8:263-269.
25. Grmec S, Kupnik D. Does the Mainz Emergency Evaluation Scoring (MEES) in combination with capnometry (MEESc) help in the prognosis of outcome from cardiopulmonary resuscitation in a prehospital setting? Resuscitation. 2003;58:89-96.
26. Grmec S, Lah K, Tusek-Bunc K. Difference in end-tidal CO2 between asphyxia cardiac arrest and ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest in the prehospital setting. Crit Care. 2003;7: R139-R144.
27. Mauer D, Schneider T, Elich D, Dick W. Carbon dioxide levels during pre-hospital active compression-decompression versus standard cardiopulmonary resuscitation. Resuscitation. 1998;39:67-74.
28. Sanders AB, Kern KB, Otto CW, Milander MM, Ewy GA. End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation: a prognostic indicator for survival. JAMA. 1989;262:1347-1351.
29. Entholzner E, Felber A, Mielke L, Hargasser S, Breinbauer B, Hundelshausen VB, Hipp R. Assessment of end-tidal CO2 measurement in reanimation. Anasthesiol Intensivmed Notfallmed Schmerzther. 1992;27: 473-476.
30. Garnett AR, Ornato JP, Gonzalez ER, Johnson EB. End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation. JAMA. 1987; 257:512-515.
31. Bhende MS, Karasic DG, Karasic RB. End-tidal carbon dioxide changes during cardiopulmonary resuscitation after experimental asphyxial cardiac arrest. Am J Emerg Med. 1996;14:349-350.
32. Ahrens T, Schallom L, Bettorf K, Ellner S, Hurt G, O'Mara V, Ludwig J, George W, Marino T, Shannon W. End-tidal carbon dioxide measurements as a prognostic indicator of outcome in cardiac arrest. Am J Crit Care. 2001;10:391-398.
33. Cantineau JP, Lambert Y, Merckx P, Reynaud P, Porte F, Bertrand C, Duvaldestin P. End-tidal carbon dioxide during cardiopulmonary resuscitation in humans presenting mostly with asystole: a predictor of outcome. Crit Care Med. 1996;24:791-796.
34. Kellum JA, Pinsky MR. Use of vasopressor agents in critically ill patients. Curr Opin Crit Care. 2002;8:236-241.
35. Zaritsky AL. Catecholamines, inotropic medications, and vasopressor agents. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient. 3rd ed. Baltimore, Md: Williams & Wilkins; 1994:387-404.
36. Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B. Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system. Crit Care Med. 1995;23:1061-1066.
37. Bonhomme L, Benhamou D, Comoy E, Preaux N. Stability of epinephrine in alkalinized solutions. Ann Emerg Med. 1990;19:1242-1244.
38. Ellis AK, Day JH. Diagnosis and management of anaphylaxis. CMAJ. 2003;169:307-311.
39. Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313-2319.
40. Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med. 2004;30:1276-1291.
41. American Heart Association in collaboration with International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science, Part 6: advanced cardiovascular life support: Section 6: pharmacology II. Agents to optimize cardiac output and blood pressure. Circulation. 2000;102(suppl I):I129-I135.
42. Delmas A, Leone M, Rousseau S, Albanese J, Martin C. Clinical review: vasopressin and terlipressin in septic shock patients. Crit Care. 2005;9: 212-222.
43. Marin C, Eon B, Saux P, Aknin P, Gouin F. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med. 1990;18:282-285.
44. Bellomo R, Giantomasso DD. Noradrenaline and the kidney: friends or foes? Crit Care. 2001;5:294-298.
45. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356:2139-2143.
46. Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest. 2003;123:1266-1275.
47. Ruffolo RR Jr. The pharmacology of dobutamine. Am J Med Sci. 1987; 294:244-248.
48. Alousi AA, Johnson DC. Pharmacology of the bipyridines: amrinone and milrinone. Circulation. 1986;73(suppl III):III10-III24.
49. Edelson J, Stroshane R, Benziger DP, Cody R, Benotti J, Hood WB Jr, Chatterjee K, Luczkowec C, Krebs C, Schwartz R. Pharmacokinetics of the bipyridines amrinone and milrinone. Circulation. 1986;73(suppl III): III145-III152.
50. Stueven HA, Thompson B, Aprahamian C, Tonsfeldt DJ, Kastenson EH. The effectiveness of calcium chloride in refractory electromechanical dissociation. Ann Emerg Med. 1985;14:626-629.
51. Stueven H, Thompson BM, Aprahamian C, Darin JC. Use of calcium in prehospital cardiac arrest. Ann Emerg Med. 1983;12:136-139.
52. Ramoska EA, Spiller HA, Winter M, Borys D. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med. 1993;22:196-200.
53. Urban P, Scheidegger D, Buchmann B, Barth D. Cardiac arrest and blood ionized calcium levels. Ann Intern Med. 1988;109:110-113.
54. Cardenas-Rivero N, Chernow B, Stoiko MA, Nussbaum SR, Todres ID. Hypocalcemia in critically ill children. J Pediatr. 1989;114:946-951.
55. DiDomenico RJ, Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, Schumock GT. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother. 2004;38:649-660.
56. Kirsten R, Nelson K, Kirsten D, Heintz B. Clinical pharmacokinetics of vasodilators. Part II. Clin Pharmacokinet. 1998;35:9-36.
57. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356: 411-417.
58. Zerbe NF, Wagner BK. Use of vitamin B12 in the treatment and prevention of nitroprusside-induced cyanide toxicity. Crit Care Med. 1993; 21:465-467.
59. Rindone JP, Sloane EP. Cyanide toxicity from sodium nitroprusside: risks and management [published correction appears in Ann Pharmacother. 1992;26:1160].
60. Ann Pharmacother. 1992;26:515-519.
61. Ditchey RV, Lindenfeld J. Potential adverse effects of volume loading on perfusion of vital organs during closed-chest resuscitation. Circulation. 1984;69:181-189.
62. Gentile NT, Martin GB, Appleton TJ, Moeggenberg J, Paradis NA, Nowak RM. Effects of arterial and venous volume infusion on coronary perfusion pressures during canine CPR. Resuscitation. 1991;22:55-63.
63. Jameson SJ, Mateer JR, DeBehnke DJ. Early volume expansion during cardiopulmonary resuscitation. Resuscitation. 1993;26:243-250.
64. Voorhees WD, Ralston SH, Kougias C, Schmitz PM. Fluid loading with whole blood or Ringer's lactate solution during CPR in dogs. Resuscitation. 1987;15:113-123.
65. Fischer M, Dahmen A, Standop J, Hagendorff A, Hoeft A, Krep H. Effects of hypertonic saline on myocardial blood flow in a porcine model of prolonged cardiac arrest. Resuscitation. 2002;54:269-280.
66. Breil M, Krep H, Sinn D, Hagendorff A, Dahmen A, Eichelkraut W, Hoeft A, Fischer M. Hypertonic saline improves myocardial blood flow during CPR, but is not enhanced further by the addition of hydroxy ethyl starch. Resuscitation. 2003;56:307-317.
67. Kette F, Weil MH, Gazmuri RJ. Buffer solutions may compromise cardiac resuscitation by reducing coronary perfusion pressure. JAMA. 1991;266:2121-2126.
68. Graf H, Leach W, Arieff AI. Evidence for a detrimental effect of bicarbonate therapy in hypoxic lactic acidosis. Science. 1985;227:754-756.
69. Katz LM, Wang Y, Rockoff S, Bouldin TW. Low-dose Carbicarb improves cerebral outcome after asphyxial cardiac arrest in rats. Ann Emerg Med. 2002;39:359-365.
70. Sun S, Weil MH, Tang W, Fukui M. Effects of buffer agents on post-resuscitation myocardial dysfunction. Crit Care Med. 1996;24: 2035-2041.
71. Blecic S, De Backer D, Deleuze M, Vachiery JL, Vincent JL. Correction of metabolic acidosis in experimental CPR: a comparative study of sodium bicarbonate, carbicarb, and dextrose. Ann Emerg Med. 1991;20: 235-238.
72. Pickkers P, Dormans TP, Russel FG, Hughes AD, Thien T, Schaper N, Smits P. Direct vascular effects of furosemide in humans. Circulation. 1997;96:1847-1852.
73. Mehta RL, Pascual MT, Soroko S, Chertow GM. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002;288: 2547-2553.